(2025)
Aspergillus terreus sectorization: a morphological phenomenon shedding light on amphotericin B resistance mechanism.
mBio 16(4),
e0392624.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Microbiome in health and disease
- Systems biology of infectious diseases
- Personalized nutrition
Publications
(2025)
Unveiling immune interference: how the dendritic cell response to co-infection with Aspergillus fumigatus is modulated by human cytomegalovirus and its virokine CMVIL-10.
mBio
[Epub ahead of print]
(2025)
Antibacterial siderophores of Pandoraea pathogens and their impact on the diseased lung microbiota.
Angew Chem Int Ed 64(24),
e202505714.
(2025)
A bioenergetic basis for multiorgan dysfunction in sepsis.
bioRxiv
[Preprint]
(2025)
Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD.
Cell Metab
[In press]
(2025)
The murine lung microbiome is disbalanced by the human-pathogenic fungus Aspergillus fumigatus resulting in enrichment of anaerobic bacteria.
Cell Rep 44(3),
115442.
(2025)
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease.
Microbiome 13(1),
10.
(2025)
Deletion of the mouse homolog of human FHR1 (muFHR1) alleviates Atherosclerosis in ApoE-/- mice.
Int J Med Sci
[In press]
(2025)
An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial.
Nature Medicine 31(7),
2255-2268.
(2025)
Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity.
Cell Metab
[In press]